Significant correlations between baseline concentrations of C1M, a marker of soft tissue destruction, have previously been observed with CRP concentrations and structural damage in MTX-IR patients with RA, indicating the potential prognostic utility of this marker [27]. The gene discussed is CRP; the disease is rheumatoid arthritis.